MedRhythms' InTandem® Rehabilitation System Achieves Medicare Approval
In a significant development for chronic stroke patients, MedRhythms, Inc. has announced that its flagship rehabilitation system, InTandem®, has received final pricing determination from the Centers for Medicare and Medicaid Services (CMS). This approval will facilitate access to InTandem's transformative therapy for those struggling with gait impairments caused by chronic strokes.
Understanding the InTandem® System
InTandem® is an innovative rehabilitation device that leverages music and technology to assist in recovery for patients with walking difficulties resulting from strokes. It utilizes rhythmic auditory stimulation (RAS) to provide a therapeutic environment that is both engaging and effective. By integrating clinical-grade gait sensors with a sophisticated hardware control unit, InTandem is designed to make rehabilitation easier and more effective in a home setting.
Medicare Payment Determination and Pricing
The pricing determination for the Healthcare Common Procedure Coding System (HCPCS) code E3200 will take effect for claims with dates of service on or after April 1, 2025. This means that the monthly Medicare payment amounts will be based on commercial pricing for the InTandem system.
CEO's Statement on the CMS Approval
Brian Harris, the CEO and Co-Founder of MedRhythms, expressed his gratitude for the CMS's decision, stating, "We founded MedRhythms and developed InTandem to bring an innovative, transformational device into the lives of people living with chronic stroke walking impairments. Achieving this key milestone is another crucial step in ensuring patients in need can access InTandem. We thank CMS for their consideration." His remarks highlight the company's commitment to enhancing the lives of stroke survivors.
The Technology Behind InTandem®
The InTandem® system operates using a combination of music and advanced algorithms to promote better walking patterns. The device provides personalized therapy sessions tailored to the needs of individual users, motivating patients to engage in their rehabilitation actively. Its design aims to facilitate improvements in gait quality and speed, vital for enhancing overall health outcomes.
Accessing InTandem® for Rehabilitation
Individuals with stroke-related walking impairments can learn more about InTandem by visiting the official website. Here, patients and caregivers can check eligibility and schedule personal information calls regarding the device's usage and benefits.
InTandem® Usage and Effectiveness
The InTandem® system is specifically indicated for improving walking and ambulation among chronic stroke patients. Its use is intended for home environments, providing an accessible solution for patients who require physical rehabilitation. The incorporation of cutting-edge technology aims to maximize therapeutic outcomes efficiently and effectively.
About MedRhythms
MedRhythms is at the forefront of developing innovative neurotherapeutic solutions designed to enhance mobility and functional outcomes through a proprietary technology platform. The company's advancements combine neuroscience with music and sensor-based applications, targeting various neurological conditions like strokes, multiple sclerosis, and Parkinson's disease. MedRhythms continues to invest in research and development to expand its product pipeline and address the needs of patients worldwide.
Frequently Asked Questions
What is InTandem®?
InTandem® is a rehabilitation system designed by MedRhythms to assist individuals with chronic stroke-related walking impairments through rhythmic auditory stimulation.
When will Medicare payments for InTandem® take effect?
The pricing determination for InTandem® will take effect for claims with service dates on or after April 1, 2025.
How does InTandem® work?
InTandem® uses music and advanced gait sensors to provide personalized therapy aimed at improving walking patterns and overall mobility.
Who can benefit from using InTandem®?
Individuals living with chronic stroke-related gait impairments are the primary beneficiaries of the InTandem® rehabilitation system.
Where can I find more information about MedRhythms?
Additional information regarding MedRhythms and the InTandem® system can be found on the official MedRhythms website.
